Evidence map›Paper›PMID 40420722›Full record

ArticleJournal of diabetes investigation2025

A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes.

Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

Abstract readCase Reports
In one paragraph

Article in Journal of diabetes investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kumiko TajimaDepartment of Internal Medicine, Japan Community Health Care Organization Gunma Central Hospital, Maebashi, Japan.ORCID https://orcid.org/0009-0006-3723-5972
Yushi HirotaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID https://orcid.org/0000-0002-3035-4155
Tomofumi TakayoshiDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Wataru OgawaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID https://orcid.org/0000-0002-0432-4366

Funding

JSPS KAKENHI 19K08981the Research on Standardizing the Treatment of Rare Diseases Causing Diabetes Through the Creation of a Registry of the Japan Diabetes Societythe Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare of Japan 24FC1015
6 · The paper itself

Abstract

A 33-year-old man presented with short stature, thin build, hearing impairment, Rieger anomaly, and a history of inguinal hernia. He also exhibited characteristic facies, including a triangular face with a small chin, deeply set eyes, and low-set ears. He was born with intrauterine growth restriction and developed diabetes during adolescence, requiring high-dose insulin therapy. For 19 years, an accurate diagnosis was not made. We performed direct sequencing of the insulin receptor gene and exons 11-16 of the PIK3R1 gene, identifying a c.1957A>T mutation (p.Lys653*) in the PIK3R1 gene, which confirmed a diagnosis of SHORT syndrome. Suspecting SHORT syndrome in individuals who exhibit some of its typical symptoms may facilitate an accurate diagnosis and enable effective management of this condition.

Indexed as

Class Ia Phosphatidylinositol 3-KinaseDiabetes MellitusGrowth DisordersMutationAdultHumansHypercalcemiaMaleMetabolic DiseasesNephrocalcinosisClass Ia Phosphatidylinositol 3-KinasePIK3R1 protein, humanAdolescentInsulin resistanceIntrauterine growth restriction

Identifiers

PMID40420722
PMCPMC12315255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.